A61K 41/0033
Sonodynamic cancer therapy with sonochemically active agents or sonosensitizers, having their cytotoxic
Official title: {Sonodynamic cancer therapy with sonochemically active agents or sonosensitizers, having their cytotoxic effects enhanced through application of ultrasounds (ultrasound therapy per se A61N7/00)}
A61K41/0033 (Sonodynamic cancer therapy with sonochemically active agents or sonosensitizers, having their cytotoxic) appears on 104 US grants and 175 published applications in this corpus.
Search patents in A61K- Granted patents
- 104
- Published applications
- 175
- Assignees
- 103
- Inventors
- 337
- Latest grant
- 22 Sep 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1998 | 2 | 0 |
| 1999 | 0 | 0 |
| 2000 | 0 | 0 |
| 2001 | 8 | 2 |
| 2002 | 4 | 4 |
| 2003 | 2 | 6 |
| 2004 | 3 | 4 |
| 2005 | 1 | 4 |
| 2006 | 2 | 2 |
| 2007 | 1 | 0 |
| 2008 | 2 | 7 |
| 2009 | 3 | 2 |
| 2010 | 3 | 4 |
| 2011 | 0 | 2 |
| 2012 | 1 | 4 |
| 2013 | 1 | 5 |
| 2014 | 5 | 4 |
| 2015 | 4 | 6 |
| 2016 | 1 | 5 |
| 2017 | 3 | 3 |
| 2018 | 3 | 8 |
| 2019 | 5 | 7 |
| 2020 | 2 | 10 |
| 2021 | 4 | 13 |
| 2022 | 7 | 17 |
| 2023 | 10 | 20 |
| 2024 | 16 | 22 |
| 2025 | 4 | 8 |
| 2026 | 7 | 6 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Recent patents
- Methods of using ultrasound waves for sonodynamic therapy22 Sep 2026US 12,741,161 B2Alpheus Medical, Inc.
- Cancer treatment methods using thermotherapy and/or enhanced immunotherapy15 Sep 2026US 12,734,238 B2
- Compositions and methods for targeted delivery of therapeutics using carriers25 Aug 2026US 12,714,676 B2Vesselon, Inc.
- Hybrid polymer-ceramic particles, methods for preparing the same and uses thereof23 Jun 2026US 12,661,320 B2Technion Research & Development Foundation Limited
- Microbubble-chemotherapeutic agent complex for sonodynamic therapy26 May 2026US 12,636,379 B2Sonotarg Limited
- Sonosensitization1 Oct 2026US 2026/0295046 A1SonalaSense, Inc.
- Targeting Microbubbles17 Sep 2026US 2026/0273061 A1California Institute of Technology
- Patient interface for facilitating non-invasive acoustic delivery10 Sep 2026US 2026/0263843 A1Alpheus Medical, Inc.
- Ultrasound arrays for enhanced sonodynamic therapy for treating cancer22 Jan 2026US 2026/0021327 A1Alpheus Medical, Inc.
- Ultrasound ablation enhanced by bubbles formed from a cluster composition administrated to a patient8 Jan 2026US 2026/0007751 A1Exact Therapeutics AS
Most cited
By later US patents
- Tumor-targeted optical contrast agents142US 7,198,778 B2Mallinckrodt Inc. · 2007
- Compounds106US 6,350,431 B1Nycomed Imaging AS · 2002
- Delivery of an agent103US 6,812,204 B1Gendel Limited · 2004
- Sonodynamic therapy using an ultrasound sensitizer compound93US 6,498,945 B1Amersham Health AS · 2002
- Dyes78US 6,180,085 B2Mallinckrodt Inc. · 2001